ArticleNeural regeneration research2022

Designing nanocarriers to overcome the limitations in conventional drug administration for Parkinson's disease.

Rafael A Garcia-Munoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.